Apixaban in Patients With Left Ventricular Thrombus

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 18, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Left Ventricular Thrombus
Interventions
DRUG

Apixaban

5 mg twice daily, on top of standards of care.

DRUG

Warfarin

Warfarin, oral tablets, to achieve international normalized ratio (INR) of 2-3, on top of standards of care, as per updated guidelines of acue coronary syndrome management recommendations

Trial Locations (1)

Unknown

Saud AlBabtain Cardiac Center, Dammam

All Listed Sponsors
lead

Saud Al Babtain Cardiac Center

OTHER_GOV

NCT05208398 - Apixaban in Patients With Left Ventricular Thrombus | Biotech Hunter | Biotech Hunter